Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion type Assertion NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_head.
- NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion description "[We found that the methylenetetrahydrofolate reductase variant CT and CT+TT genotypes decreased cervix cancer risk, statistically significant (OR:0.30, 95% CI: 0.18-0.51, P<0.001 for CT and OR:0.29, 95% CI: 0.18-0.49, P=0.0000006 for CT+TT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_provenance.
- NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion evidence source_evidence_literature NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_provenance.
- NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion SIO_000772 18351371 NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_provenance.
- NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion wasDerivedFrom befree-20140225 NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_provenance.
- NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_assertion wasGeneratedBy ECO_0000203 NP264320.RA9Poduo3nTMbYzImok8HfIooGxHMyZxc70b6g4MaBWMA130_provenance.